Astellas Pharma, Inc. (ALPMF)
15.85
-0.40
(-2.46%)
USD |
OTCM |
Aug 24, 16:00
Astellas Pharma Price to Book Value : 2.378 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.378 |
| August 21, 2026 | 2.438 |
| August 20, 2026 | 2.468 |
| August 19, 2026 | 2.280 |
| August 18, 2026 | 2.280 |
| August 17, 2026 | 2.370 |
| August 14, 2026 | 2.423 |
| August 13, 2026 | 2.018 |
| August 12, 2026 | 2.408 |
| August 11, 2026 | 2.408 |
| August 10, 2026 | 2.235 |
| August 07, 2026 | 2.408 |
| August 06, 2026 | 1.958 |
| August 05, 2026 | 1.928 |
| August 04, 2026 | 1.928 |
| August 03, 2026 | 2.066 |
| July 31, 2026 | 2.213 |
| July 30, 2026 | 2.303 |
| July 29, 2026 | 2.303 |
| July 28, 2026 | 2.153 |
| July 27, 2026 | 2.213 |
| July 24, 2026 | 1.928 |
| July 23, 2026 | 1.928 |
| July 22, 2026 | 1.928 |
| July 21, 2026 | 1.928 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.175 |
| July 17, 2026 | 2.051 |
| July 16, 2026 | 1.928 |
| July 15, 2026 | 1.928 |
| July 14, 2026 | 1.928 |
| July 13, 2026 | 1.996 |
| July 10, 2026 | 1.928 |
| July 09, 2026 | 2.138 |
| July 08, 2026 | 1.928 |
| July 07, 2026 | 2.190 |
| July 06, 2026 | 2.190 |
| July 02, 2026 | 2.122 |
| July 01, 2026 | 2.122 |
| June 30, 2026 | 2.175 |
| June 29, 2026 | 2.130 |
| June 26, 2026 | 2.213 |
| June 25, 2026 | 2.002 |
| June 24, 2026 | 2.002 |
| June 23, 2026 | 2.058 |
| June 22, 2026 | 2.111 |
| June 18, 2026 | 2.275 |
| June 17, 2026 | 2.111 |
| June 16, 2026 | 2.088 |
| June 15, 2026 | 2.146 |
| June 12, 2026 | 2.331 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Daiichi Sankyo Co., Ltd. | 3.128 |
| Takeda Pharmaceutical Co., Ltd. | 1.247 |
| Eisai Co., Ltd. | 1.535 |
| Chugai Pharmaceutical Co., Ltd. | 5.755 |
| Santen Pharmaceutical Co., Ltd. | 2.048 |
Price to Book Value Related Metrics
| PE Ratio | 12.09 |
| PS Ratio | 1.936 |
| PEG Ratio | 0.0379 |
| Price to Free Cash Flow | 9.568 |
| Price | 15.85 |
| Earnings Yield | 8.27% |
| Market Cap | 28.42B |
| PEGY Ratio | 0.0376 |
| Operating PE Ratio | 8.899 |
| Normalized PE Ratio | 12.09 |